Darlifarnib is an investigational next-generation farnesyl transferase inhibitor designed to interfere with cellular pathways ...

When the kidney cancer known as renal cell carcinoma spreads to other places (metastatic) or comes back after remission (recurrent), you may need different types of treatment. Surgery can remove renal ...

In this segment on advanced renal cell carcinoma, Dr. Wulff focuses on the role of cabozantinib across different treatment settings and how clinicians decide between monotherapy and combination ...

Shares of Kura Oncology rose after the company said its potential treatment for clear cell renal cell carcinoma, or ccRCC, demonstrated robust antitumor activity and a manageable safety profile in ...

In this segment on advanced renal cell carcinoma, Dr. McGregor focuses on how clinicians move beyond guideline ...

Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI ...

Kura Oncology (KURA) stock rises as the company posts data from a Phase 1 trial for its experimental kidney cancer therapy, darlifarnib. Read more here.

OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...

Data build on findings presented at ESMO 2025 and support potential of darlifarnib to overcome resistance and resensitize ...

Advanced Urology founder Dr. Jitesh Patel brings histotripsy to Atlanta — a non-invasive, scalpel-free breakthrough for ...

Investing.com -- Kura Oncology (NASDAQ:KURA) shares rose 9% Friday following the release of preliminary trial data showing its drug combination demonstrated activity in patients with clear cell renal ...